General - Press Releases

Date	Title	Company
17-Apr-2023	ECCMID 2023: Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja® (cefiderocol) Against Some of the Most Difficult-to-Treat Gram-Negative Bacterial Pathogens	Businesswire
17-Apr-2023	Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Alzheimer’s Dementia	Businesswire
16-Apr-2023	Preclinical Data on Volastra Therapeutics’ Two Novel and Differentiated KIF18A Inhibitors Presented at AACR 2023	Businesswire
16-Apr-2023	Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study	Businesswire
16-Apr-2023	Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.	Businesswire
15-Apr-2023	Pandemic Accord Must Keep IP Waiver Provisions, says AHF	Businesswire
15-Apr-2023	EUROAPI: Availability of the 2022 Universal Registration Document, Including the Annual Financial Report	Businesswire
14-Apr-2023	MEI Pharma Announces 1-for-20 Reverse Stock Split	Businesswire
14-Apr-2023	Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023	Businesswire
14-Apr-2023	Sensient Announces Conference Call	Businesswire
14-Apr-2023	Rapid Dose Announces Filing of Corrective Disclosure	Businesswire
14-Apr-2023	China Must Ensure Safety Is Paramount in Biotech Push, says AHF	Businesswire
14-Apr-2023	Rapid Dose Announces Board of Director Changes	Businesswire
14-Apr-2023	Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics	Businesswire
14-Apr-2023	MiNA Therapeutics Presents Late-Breaking Positive Phase 1b Data for MTL-CEBPA in Combination with an Anti-PD1 Checkpoint Inhibitor at the Annual American Association of Cancer Research (AACR) Meeting	Businesswire
14-Apr-2023	Onxeo Will Publish Its Full-year Results on April 21, 2023	Businesswire
14-Apr-2023	Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC	Businesswire
14-Apr-2023	ArsenalBio Announces Presentation of Six Abstracts at AACR Annual Meeting Highlighting Programmable Cell Therapy Progress	Businesswire
14-Apr-2023	Horizon Therapeutics plc to Release First-Quarter 2023 Financial Results on May 3, 2023	Businesswire
14-Apr-2023	Generational Equity Advises The Rasa Group in its Sale to Pharma-Care	Businesswire